(1)G Bartsch, W Catalona, M Gospodarowicz, F Abbas, C Abbou, Y Arai, M Bolla, P Conort, D Dearnaley, A Gelet, R Lee, M Menon, T Piechauid, J Trachtenberg, G Vallancien: New Developments in the Treatment of Localized Prostate Cancer. In McConnell J, Denis L, Akaza H, Khoury S, Schalken J, eds, PROSTATE CANCER, 6 th International Consultation on New Developments in Prostate Cancer and Prostate Disease, edn. 2006, Editions 21, 277-308, 2006.
(2)Satoh M, Ito A and Arai Y: Laparoscopic Retroperitoneal Lymph Node Dissection: Extraperitoneal Approach Recent Advances in Endourology 7 209-218, 2006.
(8) 荒井陽一: DVD 腹腔鏡で見る泌尿器科開放手術シリーズ 神経温存前立腺全摘術① インターメディカ 2006
(9) 荒井陽一 : 間質性膀胱炎 今日の治療方針 2006 医学書院 2006.3
論文発表
英文原著
(1)Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y: Health-related qualityof life after intensity modulated radiation therapy for localized prostate cancer:comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol 36(4): 224-230, 2006.
(2)Namiki S, Egawa S, Terachi T, Matsubara A, Igawa M, Terai A, Tochigi T, Ioritani N, Saito S, Arai Y: Changes in quality of life in the first year after radical prostatectomy by retropubic, laparoscopic, and perineal approach: multi-institutional longitudinal study in Japan . Urology 67: 321-327, 2006.
(3)Namiki S, Ishidoya S, Saito S, Satoh M, Tochigi T, Ioritani N, Yoshimura K, Terai A, Arai Y: Natural history of voiding function after radical retropubic prostatectomy. Urology 68: 142-147, 2006.
(4)Namiki S, Satoh T, Baba S, Ishiyama H, Hayakawa K, Saito S, Arai Y.: Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology, 68(6): 1230-6, Epub 2006 Dec 4.
( 6)Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y, Miyagi T. : Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem. 2006 Mar 24; 281(12): 7756-64. Epub 2006 Jan 20.
(7)Saito S, Namiki S, Numahata K, Satoh M, Ishidoya S, Ito A, Arai Y. : Relevance of postcatheter removal incontinence to postoperative urinary function after radical prostatectomy. Int J Urol. Sep;13(9): 1191-6, 2006.
(8)Wang H, Satoh M, Abe H, Sunamura M, Moriya T, Ishidoya S, Saito S, Hamada H, Arai Y: Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model.Urology. Sep; 68(3): 674-81, 2006.
(9)Kaiho Y, Kamo I, Chancellor M, Arai Y, de Groat WC, Yoshimura N. : Role of Noradrenergic Pathways in Sneeze-induced Urethral Continence Reflex in Rats. Am J Physiol Renal Physiol. 2006 Oct 17.(10)Shimada S, Nakagawa H, Shintaku I, Saito S, Arai Y. : Acute renal failure as a result of bilateral ureteral obstruction by Candida a lbicans fungus balls. Int J Urol. 2006 Aug: 13(8):1121-2. (11)Sakai K, Konda R, Ota S, Kuji S, Abe Y, Hatakeyama T, Takeda A, Arai Y: Assessment of renal cortical damage by 99m-technetium dimercaptosuccinic acid (DMSA) renal scan in children with vesicoureteral reflux (VUR) under the age of 1 year. Pediatr Nephrol 21(9): 1340-1341, 2006.
(12)Aoki H, Ishidoya S, Ito A, Endoh M, Shimazui T, Arai Y: Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Int.J.Urol. 13(9), 1254-1258, 2006.
(13)Fujimoto K, Hirao Y, Masumori N, Arai Y, Yamanaka H, Kato T and Miyazawa K : Prostate-specfic antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: Aretrospective multi-institutional study Int J Uro 13, 543-549, 2006.
(14)Arai Y, Takeda A, Taki Y, Okada Y and Ogawa O and The Tohoku-Kyoto Urinary Reconstruction study group: 5-year interval change in voiding function of orthotopic ileal neobladder Int J Urol 13(6): 703-706, 2006.
(15)Terai A, yoshimura K, Ueda K, Utsunomiya N, Kohei N and Arai Y : Clinical outcome of tubeless cutaneous ureterostomy by the Toyoda method: Int J Urology 13, 891-895, 2006.
(16)Terai A, yoshimura K, Ueda N, Utsunomiya N, Kohei N, Arai Y and Watanabe Y : DYNAMIC Contrast-enhanced Subtraction Magnetic Resonance Imagine in Diagnostics of Testicular Torsion: Urology 67(6) : 1278-1282 , 2006.
(17)Ishimura H, Takahashi T, Nakagawa H, Nishimura S, Arai Y, Horikawa Y, Habuchi T, Miyoshi E, Kyan A, Hagisawa S, Ohyama C.: N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res. 2006 Apr 15;12(8):2506-11.
(18)Nakamura Y, Suzuki T, Fukuda T, Ito A, Endo M, Moriya T, Arai Y, Sasano H. : Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate. 2006 Jun 15;66(9): 1005-12, 2006.
(19)Hoshi S, Yamaguchi O, Fujioka T, Arai Y, Tomita Y, Habuchi T, Ohyama C, Suzuki T, Orikasa S: The Tohoku Prostate Cancer Study Group. A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer. Int J Clin Oncol. 2006 Aug; 11(4): 303-8.
(20)Wang H , Satoh M, Abe H, Sunamura M, Moriya T, Ishidoya S, Saito S, Hamada H and Arai Y: Oncolytic viral therapy via bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model. Urology 68:674-681, 2006.